EF Hutton has initiated coverage on ImmunityBio Inc. (NASDAQ:IBRX), a vertically integrated biotechnology company developing ...

Yet another therapy with FDA accelerated approval suffers a setback; Sage’s tough year continues; Sanofi drops $326 million ...

Early detection is critical when it comes to curing diseases like cancer, but not everyone has easy access to screening tools ...

Medical expenses and being forced out of work mean cancer patients face significant financial challenges, with breast cancer ...

EMA committee recommends approval of LINDIS Biotech’s Korjuny to treat malignant ascites MA in adults with EpCAM-positive carcinomas: Munich, Germany Wednesday, October 23, 2024 ...

Early detection is critical when it comes to curing diseases like cancer, but not everyone has easy access to screening tools.

EF Hutton initiated coverage of ImmunityBio (IBRX) with a Buy rating and $30 price target ImmunityBio is a late-stage clinical biotechnology ...

According to a new study from scientists at The University of Texas at Arlington, Chan-Zuckerberg Biohub, and Stanford ...

Early detection is critical when it comes to curing diseases like cancer, but not everyone has easy access to screening tools ...

Prostavive stands out with its holistic approach to prostate health utilizing a blend of natural ingredients to reduce ...

Roasted pumpkin seeds offer numerous health benefits, including supporting weight loss and heart health, boosting immunity, ...

Patients with cancer have higher rates of bankruptcy and debt collections and lower credit scores — issues that can persist ...